Cielica, E.; Łaba, A.; Milkiewicz, P.; Kruk, B.; Kempinska-Podhorodecka, A.; Kłos, P.; Rodrigues, P.M.; Val, B.; Perugorria, M.J.; Banales, J.M.;
et al. The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases. Cells 2025, 14, 1137.
https://doi.org/10.3390/cells14151137
AMA Style
Cielica E, Łaba A, Milkiewicz P, Kruk B, Kempinska-Podhorodecka A, Kłos P, Rodrigues PM, Val B, Perugorria MJ, Banales JM,
et al. The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases. Cells. 2025; 14(15):1137.
https://doi.org/10.3390/cells14151137
Chicago/Turabian Style
Cielica, Eliza, Alicja Łaba, Piotr Milkiewicz, Beata Kruk, Agnieszka Kempinska-Podhorodecka, Patrycja Kłos, Pedro M. Rodrigues, Beatriz Val, Maria J. Perugorria, Jesus M. Banales,
and et al. 2025. "The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases" Cells 14, no. 15: 1137.
https://doi.org/10.3390/cells14151137
APA Style
Cielica, E., Łaba, A., Milkiewicz, P., Kruk, B., Kempinska-Podhorodecka, A., Kłos, P., Rodrigues, P. M., Val, B., Perugorria, M. J., Banales, J. M., & Milkiewicz, M.
(2025). The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases. Cells, 14(15), 1137.
https://doi.org/10.3390/cells14151137
